CytoMed Therapeutics Limited Share Price
Equities
GDTC
SGXZ17669631
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -1.94% | -5.16% | -58.78% |
Sales 2024 * | 520K 43.2M | Sales 2025 * | 520K 43.2M | Capitalization | 23.31M 1.94B |
---|---|---|---|---|---|
Net income 2024 * | -1M -83.07M | Net income 2025 * | -1M -83.07M | EV / Sales 2024 * | 36.4 x |
Net cash position 2024 * | 4.36M 362M | Net cash position 2025 * | 2.33M 193M | EV / Sales 2025 * | 40.4 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-10.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.3% |
1 day | -1.94% | ||
1 week | -5.16% | ||
Current month | -4.27% | ||
1 month | -6.05% | ||
3 months | -8.18% | ||
6 months | -45.41% | ||
Current year | -58.78% |
Managers | Title | Age | Since |
---|---|---|---|
Wee Kiat Tan
CEO | Chief Executive Officer | 36 | 01/19/01 |
Yvonne Goh
DFI | Director of Finance/CFO | 35 | 01/20/01 |
Jieming Zeng
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Kong Choo
FOU | Founder | 65 | 09/18/09 |
Tao Wu
BRD | Director/Board Member | 59 | 18/23/18 |
Kei Wei Leong
BRD | Director/Board Member | 49 | 18/23/18 |
Date | Price | Change | Volume |
---|---|---|---|
23/24/23 | 2.02 | -1.94% | 825 |
22/24/22 | 2.06 | +0.98% | 651 |
21/24/21 | 2.04 | +0.49% | 3,672 |
20/24/20 | 2.03 | -4.25% | 3,963 |
17/24/17 | 2.12 | -0.47% | 5,346 |
Delayed Quote Nasdaq, May 24, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.78% | 23.31M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.55% | 21.58B | |
-11.32% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- GDTC Stock